首页 > 最新文献

Complementary Medicine Research最新文献

英文 中文
Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial. 预防 COVID-19 确诊和疑似病例的预设顺势疗法药物:一项基于社区、双盲、随机、安慰剂对照的预防性试验。
IF 1.8 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-01-29 DOI: 10.1159/000536395
Abhijit Dutta, Arijit Manna, Shubhamoy Ghosh, Malay Mundle, Madhabananda Saha, Kumar Gourav, Sukhdeb Maiti, Bhargab Chattopadhyay
<p><strong>Introduction: </strong>Homeopathic medicines have been used for decades in the prevention and treatment of infectious diseases. However, the preventive efficacy of specific homeopathic medicines in COVID-19 is not well characterized. This study aimed to evaluate the comparative efficacy of prespecified homeopathic medicines in preventing COVID-19.</p><p><strong>Methods: </strong>A community-based, double-blind, randomized, placebo-controlled trial was conducted on 4,034 participants residing in Ward No. 27 of the Howrah Municipal Corporation in India. Participants were randomized to receive one of three prespecified homeopathic medicines [Influenzinum 30C, Arsenicum album 30C, Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum®)], or placebo. The outcomes were the incidence of laboratory-confirmed and suspected cases of COVID-19 during a follow-up period of 1 month.</p><p><strong>Results: </strong>During the follow-up period, a total of 13 new laboratory-confirmed COVID-19 cases were reported in the study population. Among these, 5 cases in Influenzinum group, 2 cases in Arsenicum album group, 1 case in Oscillococcinum® group, and 5 cases in Placebo group were reported. On the other hand, number of suspected COVID-19 cases was significantly less in all the three homeopathic medicine groups compared to placebo. The least number of suspected cases reported in the Oscillococcinum® group (aOR: 0.058; 95% confidence interval [CI]: 0.029, 0.114), followed by the Arsenicum album (aOR: 0.337; 95% CI: 0.238, 0.475) and Influenzinum (aOR: 0.539; 95% CI: 0.401, 0.726) groups.</p><p><strong>Conclusion: </strong>Prespecified homeopathic medicines, particularly Oscillococcinum® and Arsenicum album 30C, may have a role in preventing COVID-19, especially in reducing the incidence of suspected or COVID-19-like respiratory illnesses. However, the result failed to demonstrate a statistically significant difference in the occurrence of confirmed cases of COVID-19 between the study groups. Further research is needed to evaluate the efficacy of these medicines in different populations and settings.</p><p><p><title>Einleitung</title>Homöopathische Arzneimittel werden seit Jahrzehnten zur Prävention und Behandlung von Infektionskrankheiten eingesetzt. Die Wirksamkeit spezifischer homöopathischer Arzneimittel zur Prophylaxe von COVID-19 ist jedoch nicht gut untersucht. Mit dieser Studie sollte die vergleichende Wirksamkeit spezifischer homöopathischer Arzneimittel bei der Prävention von COVID-19 untersucht werden.<title>Methoden</title>Es handelte sich um eine gemeindebasierte, doppelblinde, randomisierte, placebokontrollierte Studie mit 4.034 Teilnehmern, die im Bezirk Nr. 27 der Howrah Municipal Corporation in Indien lebten. Die Teilnehmer erhielten randomisiert eines von drei zuvor festgelegten homöopathischen Arzneimitteln [<italic>Influenzinum</italic> 30C, <italic>Arsenicum album</italic> 30C, <italic>Anas barbariae hepatis et cordis extrac
导言:几十年来,顺势疗法药物一直被用于预防和治疗传染病。然而,特定顺势疗法药物对 COVID-19 的预防效果尚不十分明确。本研究旨在评估预先指定的顺势疗法药物在预防 COVID-19 方面的疗效比较:方法:对居住在印度豪拉市政公司第 27 病区的 4034 名参与者进行了一项基于社区的双盲、随机、安慰剂对照试验。参与者被随机分配接受三种预先指定的顺势疗法药物(炎琥宁 30C、砒霜 30C、阿那斯-巴比妥肝脏和脊髓提取物 200K(Oscilloccinum®))中的一种或安慰剂。结果是在一个月的随访期间,COVID-19 实验室确诊病例和疑似病例的发生率:结果:在随访期间,研究人群中共报告了 13 例经实验室确诊的 COVID-19 新病例。其中,炎琥宁组5例,砒霜组2例,Oscilloccinum®组1例,安慰剂组5例。另一方面,与安慰剂组相比,所有三个顺势疗法组的 COVID-19 疑似病例数都明显减少。Oscilloccinum®组的疑似病例数最少(aOR:0.539;95%CI:0.401,0.726),其次是Asenicum album(aOR:0.337;95%CI:0.238,0.475)和Influenzinum(aOR:0.058;95%CI:0.029,0.114)组:结论:预设的顺势疗法药物,尤其是 Oscilloccinum® 和 Arsenicum album 30C 可能对预防 COVID-19 有一定作用,尤其是在降低疑似或类似 COVID-19 的呼吸道疾病发病率方面。然而,研究结果未能证明研究组之间在 COVID-19 确诊病例的发生率方面存在显著的统计学差异。需要进一步开展研究,以评估这些药物在不同人群和环境中的疗效:试验注册:CTRI/2020/09/028122,日期:2020年9月29日。试验注册:CTRI/2020/09/028122,日期:2020 年 9 月 29 日。
{"title":"Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial.","authors":"Abhijit Dutta, Arijit Manna, Shubhamoy Ghosh, Malay Mundle, Madhabananda Saha, Kumar Gourav, Sukhdeb Maiti, Bhargab Chattopadhyay","doi":"10.1159/000536395","DOIUrl":"10.1159/000536395","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Homeopathic medicines have been used for decades in the prevention and treatment of infectious diseases. However, the preventive efficacy of specific homeopathic medicines in COVID-19 is not well characterized. This study aimed to evaluate the comparative efficacy of prespecified homeopathic medicines in preventing COVID-19.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A community-based, double-blind, randomized, placebo-controlled trial was conducted on 4,034 participants residing in Ward No. 27 of the Howrah Municipal Corporation in India. Participants were randomized to receive one of three prespecified homeopathic medicines [Influenzinum 30C, Arsenicum album 30C, Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum®)], or placebo. The outcomes were the incidence of laboratory-confirmed and suspected cases of COVID-19 during a follow-up period of 1 month.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During the follow-up period, a total of 13 new laboratory-confirmed COVID-19 cases were reported in the study population. Among these, 5 cases in Influenzinum group, 2 cases in Arsenicum album group, 1 case in Oscillococcinum® group, and 5 cases in Placebo group were reported. On the other hand, number of suspected COVID-19 cases was significantly less in all the three homeopathic medicine groups compared to placebo. The least number of suspected cases reported in the Oscillococcinum® group (aOR: 0.058; 95% confidence interval [CI]: 0.029, 0.114), followed by the Arsenicum album (aOR: 0.337; 95% CI: 0.238, 0.475) and Influenzinum (aOR: 0.539; 95% CI: 0.401, 0.726) groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Prespecified homeopathic medicines, particularly Oscillococcinum® and Arsenicum album 30C, may have a role in preventing COVID-19, especially in reducing the incidence of suspected or COVID-19-like respiratory illnesses. However, the result failed to demonstrate a statistically significant difference in the occurrence of confirmed cases of COVID-19 between the study groups. Further research is needed to evaluate the efficacy of these medicines in different populations and settings.&lt;/p&gt;&lt;p&gt;&lt;p&gt;&lt;title&gt;Einleitung&lt;/title&gt;Homöopathische Arzneimittel werden seit Jahrzehnten zur Prävention und Behandlung von Infektionskrankheiten eingesetzt. Die Wirksamkeit spezifischer homöopathischer Arzneimittel zur Prophylaxe von COVID-19 ist jedoch nicht gut untersucht. Mit dieser Studie sollte die vergleichende Wirksamkeit spezifischer homöopathischer Arzneimittel bei der Prävention von COVID-19 untersucht werden.&lt;title&gt;Methoden&lt;/title&gt;Es handelte sich um eine gemeindebasierte, doppelblinde, randomisierte, placebokontrollierte Studie mit 4.034 Teilnehmern, die im Bezirk Nr. 27 der Howrah Municipal Corporation in Indien lebten. Die Teilnehmer erhielten randomisiert eines von drei zuvor festgelegten homöopathischen Arzneimitteln [&lt;italic&gt;Influenzinum&lt;/italic&gt; 30C, &lt;italic&gt;Arsenicum album&lt;/italic&gt; 30C, &lt;italic&gt;Anas barbariae hepatis et cordis extrac","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"140-148"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139575454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volitionally Regulated Breathing with Prolonged Expiration Influences Food Craving and Impulsivity. 长时间呼气的调节性呼吸会影响对食物的渴望和冲动性。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-07-17 DOI: 10.1159/000539618
Shirley Telles, Ami Gupta, Sachin Kumar Sharma, Acharya Balkrishna

Introduction: Previously, an intervention involving volitional slow breathing reduced trait food craving with protective effects on cardiac vagal activity (CVA). Breathing with a low inspiration-to-expiration (i/e) ratio also increases CVA. High CVA was separately associated with low unregulated eating and lesser impulsivity. Hence, the present study assessed breathing with a low i/e for effects on state food craving, hunger and satiety, state impulsivity, and heart rate variability (HRV) in healthy obese persons.

Methods: Forty obese persons were randomized to two groups. The intervention group (mean age ± SD, 41.15 ± 12.63, M:F, 10:10) practiced metronome-regulated breathing with low i/e at 12 breaths per minute (expiration 72% of total breath duration) and attained expiration 55.8% of total breath duration, while the active control group (mean age ± SD, 44.45 ± 11.06, M:F, 13:07) sat motionless and directed their gaze and awareness to the stationary metronome without modifying their breath consciously. The HRV was recorded before, during, and after breathing intervention (or control) (standard limb lead I, acquisition at 2,000 Hz, with an LF filter = 0.5 Hz and HF filter = 50 Hz). Time-domain and frequency-domain HRV parameters were obtained with Kubios software. State food craving, and hunger and satiety were recorded before and after the intervention/control.

Results: The intervention group decreased total state food craving scores and the sub-domains (i.e., desire to eat, positive reinforcement, lack of control and hunger), increased current satisfaction with food, decreased total state impulsivity (repeated measures ANOVA, p < 0.05 in all cases), increased HF-HRV and RMSSD (linear mixed model analyses with age and gender as fixed factors; p < 0.05 in all cases) during the intervention compared to the preceding baseline. The intervention group also showed an increase in positive mood and a decrease in aroused and negative mood states.

Conclusion: Changes in state food craving and impulsivity could be related to an increase in HRV or to changes in subjective relaxation and positive mood or to both.

导言:以前,一种涉及自愿慢速呼吸的干预措施可减少特质食物渴求,对心脏迷走神经活动(CVA)具有保护作用。低吸气呼气比(i/e)呼吸也会增加心迷走神经活动。高 CVA 分别与低无节制进食和较少冲动有关。因此,本研究评估了低吸呼比呼吸对健康肥胖者的食物渴望、饥饿和饱腹感、状态冲动性和心率变异性(HRV)的影响。方法 将 40 名肥胖者随机分为两组。干预组(平均年龄(±SD),41.15±12.63,男:女,10:10)练习节拍器调节的低i/e呼吸,每分钟12次(呼气占总呼吸时间的72%)(bpm),达到呼气占总呼吸时间的55.8%;主动对照组(平均年龄(±SD),44.45±11.06,男:女,13:07)一动不动地坐着,将目光和意识投向静止的节拍器,不有意识地调整呼吸。在呼吸干预(或控制)之前、期间和之后记录心率变异(标准肢导联 I,采集频率为 2000 Hz,低频滤波器 = 0.5 Hz,高频滤波器 = 50 Hz。时域和频域心率变异参数由 Kubios 软件获得。记录干预/对照前后的食物渴求状态、饥饿感和饱腹感。结果 与之前的基线相比,干预组在干预期间降低了状态食物渴望的总分和各子域(即进食欲望、正强化、缺乏控制和饥饿感),提高了当前对食物的满意度,降低了状态冲动的总分(重复测量方差分析,所有情况下均为 p<0.05),提高了高频心率变异和 RMSSD(线性混合模型分析,年龄和性别为固定因素;所有情况下均为 p<0.05)。干预组的积极情绪也有所上升,而亢奋和消极情绪状态则有所下降。结论 食物渴求和冲动状态的变化可能与心率变异的增加有关,也可能与主观放松和积极情绪的变化有关,或者两者兼而有之。
{"title":"Volitionally Regulated Breathing with Prolonged Expiration Influences Food Craving and Impulsivity.","authors":"Shirley Telles, Ami Gupta, Sachin Kumar Sharma, Acharya Balkrishna","doi":"10.1159/000539618","DOIUrl":"10.1159/000539618","url":null,"abstract":"<p><strong>Introduction: </strong>Previously, an intervention involving volitional slow breathing reduced trait food craving with protective effects on cardiac vagal activity (CVA). Breathing with a low inspiration-to-expiration (i/e) ratio also increases CVA. High CVA was separately associated with low unregulated eating and lesser impulsivity. Hence, the present study assessed breathing with a low i/e for effects on state food craving, hunger and satiety, state impulsivity, and heart rate variability (HRV) in healthy obese persons.</p><p><strong>Methods: </strong>Forty obese persons were randomized to two groups. The intervention group (mean age ± SD, 41.15 ± 12.63, M:F, 10:10) practiced metronome-regulated breathing with low i/e at 12 breaths per minute (expiration 72% of total breath duration) and attained expiration 55.8% of total breath duration, while the active control group (mean age ± SD, 44.45 ± 11.06, M:F, 13:07) sat motionless and directed their gaze and awareness to the stationary metronome without modifying their breath consciously. The HRV was recorded before, during, and after breathing intervention (or control) (standard limb lead I, acquisition at 2,000 Hz, with an LF filter = 0.5 Hz and HF filter = 50 Hz). Time-domain and frequency-domain HRV parameters were obtained with Kubios software. State food craving, and hunger and satiety were recorded before and after the intervention/control.</p><p><strong>Results: </strong>The intervention group decreased total state food craving scores and the sub-domains (i.e., desire to eat, positive reinforcement, lack of control and hunger), increased current satisfaction with food, decreased total state impulsivity (repeated measures ANOVA, p &lt; 0.05 in all cases), increased HF-HRV and RMSSD (linear mixed model analyses with age and gender as fixed factors; p &lt; 0.05 in all cases) during the intervention compared to the preceding baseline. The intervention group also showed an increase in positive mood and a decrease in aroused and negative mood states.</p><p><strong>Conclusion: </strong>Changes in state food craving and impulsivity could be related to an increase in HRV or to changes in subjective relaxation and positive mood or to both.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"376-389"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nurturing Hope: Reproductive Outcomes with Sinosomatics following Unsuccessful in vitro Fertilization Attempts. 孕育希望:试管婴儿尝试失败后使用体外受精术的生殖结果。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-05-20 DOI: 10.1159/000539408
Antonia Pfeiffer, Annemarie Schweizer-Arau, Roxana M Popovici, Astrid Vogel, Yumiko von Hasselbach, Florian Beissner, Karin Meissner

Introduction: For women who have experienced failed attempts at in vitro fertilization (IVF) and face medical issues, leading to infertility, the renewed effort to seek fertility treatment, coupled with decreasing likelihood of success, can exert substantial emotional and physical strains. Consequently, many couples opt to discontinue treatment before attaining pregnancy. The objective of this study was to evaluate the reproductive outcomes in patients with unsuccessful prior IVF attempts who received a complementary treatment designed to alleviate emotional distress and burden.

Patients and methods: A retrospective analysis of data from infertile patients who initiated the complementary intervention at a private clinic between January 2014 and December 2016 was conducted. Information on diagnosis, history of infertility, prior assisted reproductive technology treatments, mode of conception, and pregnancy outcomes were retrieved.

Results: The data of 133 patients with a history of one or more unsuccessful IVF treatments were analyzed. Patients had an average age of 36.7 years (±4.4 SD) and had been experiencing infertility for an average of 4.6 years (±2.7 SD). The two main causes of their infertility were endometriosis (36.1%, 48 patients) and diminished egg quality (31.6%, 42 patients). By May 2020, a significant proportion of the patients, 81.2% (108 patients), had achieved pregnancy, leading to 94 live births, which represents a 70.7% success rate. These pregnancies mostly resulted from natural cycle IVF (35.1%), donor cycles (23.4%), and conventional IVF (21.3%). The dropout rate was comparatively low at 23.3%. The median time from the start of complementary treatment to delivery was 18 months, with a range of 12-28 months.

Conclusions: This study highlights the potential value of complementary treatment approaches in conjunction with standard medical care for women who have experienced unsuccessful IVF treatments in the past and thus face a reduced chance of motherhood. The reported 71% live birth rate is notably high, indicating that the inclusion of complementary treatments may provide women with past IVF failures a tangible opportunity for achieving successful pregnancy and childbirth. However, these findings need to be confirmed through randomized controlled studies.

导言:对于尝试过体外受精(IVF)失败并面临导致不孕的医疗问题的妇女来说,重新努力寻求生育治疗,再加上成功的可能性越来越小,会给她们带来巨大的精神和身体压力。因此,许多夫妇在怀孕前选择中止治疗。本研究的目的是评估曾尝试试管婴儿但未成功的患者接受旨在减轻情绪困扰和负担的辅助治疗后的生育结果:本研究对 2014 年 1 月至 2016 年 12 月期间在一家私人诊所接受辅助治疗的不孕不育患者的数据进行了回顾性分析。检索了有关诊断、不孕症病史、之前的辅助生殖技术治疗、受孕方式和妊娠结果的信息:对133名曾有一次或多次试管婴儿治疗失败史的患者的数据进行了分析。患者平均年龄为 36.7 岁(± 4.4 SD),平均不孕时间为 4.6 年(± 2.7 SD)。导致他们不孕的两个主要原因是子宫内膜异位症(36.1%,48 名患者)和卵子质量下降(31.6%,42 名患者)。截至 2020 年 5 月,大部分患者(81.2%,108 人)已成功怀孕,活产 94 例,成功率为 70.7%。这些妊娠大多来自自然周期试管婴儿(35.1%)、捐献周期试管婴儿(23.4%)和传统试管婴儿(21.3%)。辍学率相对较低,为 23.3%。从开始辅助治疗到分娩的中位时间为 18 个月,范围在 12 到 28 个月之间:这项研究强调了辅助治疗方法与标准医疗护理相结合的潜在价值,适用于过去试管婴儿治疗不成功、因而做母亲的机会减少的妇女。据报道,71%的活产率非常高,这表明,辅助治疗的加入可能会为过去试管婴儿治疗失败的妇女提供一个成功怀孕和分娩的切实机会。不过,这些发现还需要通过随机对照研究来证实。
{"title":"Nurturing Hope: Reproductive Outcomes with Sinosomatics following Unsuccessful in vitro Fertilization Attempts.","authors":"Antonia Pfeiffer, Annemarie Schweizer-Arau, Roxana M Popovici, Astrid Vogel, Yumiko von Hasselbach, Florian Beissner, Karin Meissner","doi":"10.1159/000539408","DOIUrl":"10.1159/000539408","url":null,"abstract":"<p><strong>Introduction: </strong>For women who have experienced failed attempts at in vitro fertilization (IVF) and face medical issues, leading to infertility, the renewed effort to seek fertility treatment, coupled with decreasing likelihood of success, can exert substantial emotional and physical strains. Consequently, many couples opt to discontinue treatment before attaining pregnancy. The objective of this study was to evaluate the reproductive outcomes in patients with unsuccessful prior IVF attempts who received a complementary treatment designed to alleviate emotional distress and burden.</p><p><strong>Patients and methods: </strong>A retrospective analysis of data from infertile patients who initiated the complementary intervention at a private clinic between January 2014 and December 2016 was conducted. Information on diagnosis, history of infertility, prior assisted reproductive technology treatments, mode of conception, and pregnancy outcomes were retrieved.</p><p><strong>Results: </strong>The data of 133 patients with a history of one or more unsuccessful IVF treatments were analyzed. Patients had an average age of 36.7 years (±4.4 SD) and had been experiencing infertility for an average of 4.6 years (±2.7 SD). The two main causes of their infertility were endometriosis (36.1%, 48 patients) and diminished egg quality (31.6%, 42 patients). By May 2020, a significant proportion of the patients, 81.2% (108 patients), had achieved pregnancy, leading to 94 live births, which represents a 70.7% success rate. These pregnancies mostly resulted from natural cycle IVF (35.1%), donor cycles (23.4%), and conventional IVF (21.3%). The dropout rate was comparatively low at 23.3%. The median time from the start of complementary treatment to delivery was 18 months, with a range of 12-28 months.</p><p><strong>Conclusions: </strong>This study highlights the potential value of complementary treatment approaches in conjunction with standard medical care for women who have experienced unsuccessful IVF treatments in the past and thus face a reduced chance of motherhood. The reported 71% live birth rate is notably high, indicating that the inclusion of complementary treatments may provide women with past IVF failures a tangible opportunity for achieving successful pregnancy and childbirth. However, these findings need to be confirmed through randomized controlled studies.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"367-375"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fasting in Science and Clinics: A Report on Proceedings from the International Scientific Symposium and Conference on Fasting in Berlin (June 2023). 科学和临床中的禁食--柏林禁食国际科学研讨会和会议(2023 年 6 月)记录报告。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-08-09 DOI: 10.1159/000540668
Carolin Breinlinger, Sara Meiß, Etienne Hanslian, Stefan Jordan, Michael Boschmann, Anika Rajput Khokhar, Andreas Michalsen, Daniela A Koppold

Background: A fasting conference and scientific symposium on fasting were held in Berlin in June 2023. Researchers and clinicians from around the world shared new findings, clinical insights, and work in progress during a 3-day program.

Summary: Different fasting regimens, including prolonged, short-term, intermittent fasting, and time-restricted eating were discussed for preventive and therapeutic settings. Experimental and clinical findings shared ranged from biochemical and cellular fasting responses to fasting-mimicking agents, the role of the gut microbiome, and immunological effects. Clinically, a special focus was placed upon metabolic, autoimmune, neurodegenerative, and oncological diseases. The discussion also covered how modern technologies, practical adaptations to traditional protocols, and a supportive network of specialized physicians can assist in the practical application of fasting, among other subjects.

Key messages: Dose-response relationships, gender aspects, and the subjective experience of fasting seem promising for future research, while further investigation of religious fasting may offer deeper insights into motivational and health aspects.

背景:2023 年 6 月在柏林举行了禁食会议和禁食科学研讨会。来自世界各地的研究人员和临床医生在为期三天的会议中分享了新发现、临床见解和工作进展。摘要:会议讨论了不同的禁食方案,包括长期、短期、间歇性禁食和限时进食(TRE),用于预防和治疗。分享的实验和临床研究结果包括生化和细胞禁食反应、禁食模拟药剂、肠道微生物组的作用和免疫学效应。在临床方面,会议特别关注代谢性疾病、自身免疫性疾病、神经退行性疾病和肿瘤疾病。讨论还涉及现代技术、对传统方案的实际调整、专业医生支持网络如何帮助禁食的实际应用等主题:关键信息:剂量-反应关系、性别因素和禁食的主观体验似乎是未来研究的前景所在,而对宗教禁食的进一步调查可能会为动机和健康方面提供更深入的见解。
{"title":"Fasting in Science and Clinics: A Report on Proceedings from the International Scientific Symposium and Conference on Fasting in Berlin (June 2023).","authors":"Carolin Breinlinger, Sara Meiß, Etienne Hanslian, Stefan Jordan, Michael Boschmann, Anika Rajput Khokhar, Andreas Michalsen, Daniela A Koppold","doi":"10.1159/000540668","DOIUrl":"10.1159/000540668","url":null,"abstract":"<p><strong>Background: </strong>A fasting conference and scientific symposium on fasting were held in Berlin in June 2023. Researchers and clinicians from around the world shared new findings, clinical insights, and work in progress during a 3-day program.</p><p><strong>Summary: </strong>Different fasting regimens, including prolonged, short-term, intermittent fasting, and time-restricted eating were discussed for preventive and therapeutic settings. Experimental and clinical findings shared ranged from biochemical and cellular fasting responses to fasting-mimicking agents, the role of the gut microbiome, and immunological effects. Clinically, a special focus was placed upon metabolic, autoimmune, neurodegenerative, and oncological diseases. The discussion also covered how modern technologies, practical adaptations to traditional protocols, and a supportive network of specialized physicians can assist in the practical application of fasting, among other subjects.</p><p><strong>Key messages: </strong>Dose-response relationships, gender aspects, and the subjective experience of fasting seem promising for future research, while further investigation of religious fasting may offer deeper insights into motivational and health aspects.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"484-491"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11466443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Honey-Lime Spray as Add-On Therapy on Chemotherapy-Induced Xerostomia in Breast Cancer Patients: A Pilot Randomized Double-Blinded Controlled Trial. 蜂蜜石灰喷雾剂作为附加疗法对乳腺癌患者化疗引起的口干舌燥的影响:随机双盲对照试验。
IF 1.8 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-01-24 DOI: 10.1159/000536226
Ghazaleh Heydarirad, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Samira Ghorbanpoor, Judith Buentzel, Thomas Rampp, Mehdi Pasalar
<p><strong>Introduction: </strong>Xerostomia (dry mouth) is a common side effect among patients with cancer undergoing chemotherapy. There is no standard treatment for this symptom yet, although Persian medicine textbooks suggested some products to relieve xerostomia. We aimed to assess the efficacy of honey-lime spray in treating chemotherapy-induced xerostomia in breast cancer patients through a controlled study.</p><p><strong>Methods: </strong>In this pilot, randomized, double-blinded clinical trial conducted in Shohadaye Tajrish Hospital, Iran, the intervention group received honey-lime spray and nystatin, while the control group used distilled water plus nystatin for 2 weeks. The six-item dry mouth form and visual analog score (VAS) were used to evaluate xerostomia extent and pain, respectively.</p><p><strong>Results: </strong>The standardized value of the difference between the mean scores before and after the study was -10.21 (p < 0.001), and the effect size was estimated at 55%. Also, VAS showed a significant decrease in pain for the intervention group compared with the control group (p < 0.001). There were no serious side effects.</p><p><strong>Conclusion: </strong>Honey-lime spray may be a good treatment choice for xerostomia in chemotherapy-induced breast cancer patients, but robust trials with larger samples and prolonged follow-ups are highly recommended.</p><p><p><title>Einleitung</title>Mundtrockenheit (Xerostomie) ist eine häufige Nebenwirkung bei Krebspatienten, die sich einer Chemotherapie unterziehen. Es gibt bisher keine Standardtherapie für dieses Symptom, doch Lehrbücher der persischen Medizin schlagen einige Mittel zur Linderung von Mundtrockenheit vor. Unser Ziel war es, die Wirksamkeit von Honig-Limetten-Spray zur Behandlung von chemotherapiebedingter Mundtrockenheit bei Patientinnen mit Brustkrebs im Rahmen einer kontrollierten Studie zu untersuchen.<title>Methoden</title>In dieser randomisierten, doppelt verblindeten klinischen Pilotstudie, die im Shohadaye Tajrish Hospital im Iran durchgeführt wurde, erhielt die Interventionsgruppe zwei Wochen lang Honig-Limetten-Spray und Nystatin und die Kontrollgruppe destilliertes Wasser plus Nystatin. Ein Mundtrockenheits-Fragebogen mit sechs Items wurde zur Beurteilung der Schwere der Mundtrockenheit verwendet und eine visuelle Analogskala zur Beurteilung der Schmerzen.<title>Ergebnisse</title>Der standardisierte Wert der Differenz zwischen den mittleren Scores vor und nach der Studie betrug −10,21 (<italic>p</italic> < 0,01), und die geschätzte Effektstärke betrug 55%. Zudem zeigte die VAS eine signifikante Abnahme der Schmerzen in der Interventionsgruppe im Vergleich zur Kontrollgruppe (<italic>p</italic> < 0,01). Es traten keine schwerwiegenden Nebenwirkungen auf.<title>Schlussfolgerung</title>Honig-Limetten-Spray könnte eine gute Wahl für die Behandlung von Mundtrockenheit bei Brustkrebspatientinnen unter Chemotherapie sein, doch hierzu werden belastbare Studien m
简介口干症(口腔干燥)是接受化疗的癌症患者常见的副作用。虽然波斯医学教科书建议使用一些产品来缓解口干症,但目前还没有针对这一症状的标准治疗方法。我们旨在通过一项对照研究,评估蜂蜜石灰喷雾剂治疗乳腺癌患者化疗引起的口干舌燥的疗效:在伊朗 Shohadaye Tajrish 医院进行的这项试验性、随机、双盲临床试验中,干预组使用蜂蜜石灰喷雾剂和硝苯地平,对照组使用蒸馏水和硝苯地平,为期两周。结果显示,干预组和对照组的口干程度和疼痛程度差异的标准化值分别为 0.05 和 0.05,而对照组为 0.05 和 0.05:结果:研究前后的平均分差值的标准化值为-10.21(PC结论:蜂蜜石灰喷雾剂可能是一种很好的治疗方法:蜂蜜石灰喷雾剂可能是治疗化疗引起的乳腺癌患者口干症的良好选择,但强烈建议进行更大规模的样本试验和更长时间的随访。
{"title":"Effect of Honey-Lime Spray as Add-On Therapy on Chemotherapy-Induced Xerostomia in Breast Cancer Patients: A Pilot Randomized Double-Blinded Controlled Trial.","authors":"Ghazaleh Heydarirad, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Samira Ghorbanpoor, Judith Buentzel, Thomas Rampp, Mehdi Pasalar","doi":"10.1159/000536226","DOIUrl":"10.1159/000536226","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Xerostomia (dry mouth) is a common side effect among patients with cancer undergoing chemotherapy. There is no standard treatment for this symptom yet, although Persian medicine textbooks suggested some products to relieve xerostomia. We aimed to assess the efficacy of honey-lime spray in treating chemotherapy-induced xerostomia in breast cancer patients through a controlled study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;In this pilot, randomized, double-blinded clinical trial conducted in Shohadaye Tajrish Hospital, Iran, the intervention group received honey-lime spray and nystatin, while the control group used distilled water plus nystatin for 2 weeks. The six-item dry mouth form and visual analog score (VAS) were used to evaluate xerostomia extent and pain, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The standardized value of the difference between the mean scores before and after the study was -10.21 (p &lt; 0.001), and the effect size was estimated at 55%. Also, VAS showed a significant decrease in pain for the intervention group compared with the control group (p &lt; 0.001). There were no serious side effects.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Honey-lime spray may be a good treatment choice for xerostomia in chemotherapy-induced breast cancer patients, but robust trials with larger samples and prolonged follow-ups are highly recommended.&lt;/p&gt;&lt;p&gt;&lt;p&gt;&lt;title&gt;Einleitung&lt;/title&gt;Mundtrockenheit (Xerostomie) ist eine häufige Nebenwirkung bei Krebspatienten, die sich einer Chemotherapie unterziehen. Es gibt bisher keine Standardtherapie für dieses Symptom, doch Lehrbücher der persischen Medizin schlagen einige Mittel zur Linderung von Mundtrockenheit vor. Unser Ziel war es, die Wirksamkeit von Honig-Limetten-Spray zur Behandlung von chemotherapiebedingter Mundtrockenheit bei Patientinnen mit Brustkrebs im Rahmen einer kontrollierten Studie zu untersuchen.&lt;title&gt;Methoden&lt;/title&gt;In dieser randomisierten, doppelt verblindeten klinischen Pilotstudie, die im Shohadaye Tajrish Hospital im Iran durchgeführt wurde, erhielt die Interventionsgruppe zwei Wochen lang Honig-Limetten-Spray und Nystatin und die Kontrollgruppe destilliertes Wasser plus Nystatin. Ein Mundtrockenheits-Fragebogen mit sechs Items wurde zur Beurteilung der Schwere der Mundtrockenheit verwendet und eine visuelle Analogskala zur Beurteilung der Schmerzen.&lt;title&gt;Ergebnisse&lt;/title&gt;Der standardisierte Wert der Differenz zwischen den mittleren Scores vor und nach der Studie betrug −10,21 (&lt;italic&gt;p&lt;/italic&gt; &lt; 0,01), und die geschätzte Effektstärke betrug 55%. Zudem zeigte die VAS eine signifikante Abnahme der Schmerzen in der Interventionsgruppe im Vergleich zur Kontrollgruppe (&lt;italic&gt;p&lt;/italic&gt; &lt; 0,01). Es traten keine schwerwiegenden Nebenwirkungen auf.&lt;title&gt;Schlussfolgerung&lt;/title&gt;Honig-Limetten-Spray könnte eine gute Wahl für die Behandlung von Mundtrockenheit bei Brustkrebspatientinnen unter Chemotherapie sein, doch hierzu werden belastbare Studien m","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"133-139"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139545089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Maintenance Treatment of a Patient with Resistant Hyperthyroidism with Traditional Persian Medicine Recommendations: A Case Report and Literature Review. 用传统波斯医学建议成功维持治疗一名抗药性甲状腺功能亢进症患者:病例报告和文献综述。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-09-05 DOI: 10.1159/000541255
Mohammad Mahdi Parvizi, Sara Foolad, Ali Zeighami, Mohammad Reza Namazi, Mojtaba Heydari

Introduction: Hyperthyroidism is a common endocrinology condition that could affect several aspects of the patient's life.

Case presentation: We present a 27-year-old woman who was sent to the traditional Persian medicine (TPM) clinic with a diagnosis of uncontrolled chronic hyperthyroidism (lower levels of thyroid-stimulating hormone (TSH) and higher levels of T3 and T4) and its complications, such as developing exophthalmos, palpitations, anxiety, sleep problems, hair loss, and dry skin. The patient was under treatment with prednisolone and methimazole for up to 1 year, but no acceptable improvement was achieved. The patient received a package of TPM recommendations, which included lifestyle modification, Melissa officinalis herbal tea, and Persian barley water. The patient was followed for 1 year. After 2 months of follow-up of the patient, the level of TSH increased, and the level of T3 and T4 decreased. In addition, the patient's symptoms, including exophthalmos, palpitation, anxiety, sleep disturbance, and dryness of the skin, were improved considerably. After 3 months of consumption of the TPM-based regime and prescription, the serum levels of TSH, T3, and T4, of the patient were in normal ranges. In a 1-year follow-up of the patient, the patient's condition was stable and her thyroid function tests were normal. We hereby present the following case to be in line with the CAse REports (CARE) checklist.

Conclusion: It appears that TPM lifestyle recommendations, M. officinalis herbal tea, and Persian barley water were effective in treating the patient with uncontrolled hyperthyroidism. We recommend further studies and clinical trial designs in this regard.

简介甲状腺功能亢进症是一种常见的内分泌疾病,可能会影响患者生活的多个方面:我们为您介绍一位 27 岁的女性患者,她被送往传统波斯医学(TPM)诊所就诊,被诊断为不受控制的慢性甲状腺功能亢进症(促甲状腺激素(TSH)水平较低,T3 和 T4 水平较高)及其并发症,如眼球外翻、心悸、焦虑、睡眠问题、脱发和皮肤干燥。患者接受了长达一年的泼尼松龙和甲巯咪唑治疗,但病情没有得到可接受的改善。患者接受了一整套 TPM 建议,包括改变生活方式、香蜂草凉茶和波斯大麦水。对患者进行了为期一年的随访。随访两个月后,患者的促甲状腺激素水平上升,T3 和 T4 水平下降。此外,患者的眼球外翻、心悸、焦虑、睡眠障碍和皮肤干燥等症状也得到了明显改善。在服用基于 TPM 的疗法和处方三个月后,患者血清中的促甲状腺激素、T3 和 T4 水平均处于正常范围。在对患者一年的随访中,患者病情稳定,甲状腺功能检测正常。我们在此提出以下病例,以符合CAse REports(CARE)检查表的要求:结论:看来,TPM生活方式建议、香蜂草凉茶和波斯大麦水对治疗该名不受控制的甲状腺功能亢进症患者很有效。我们建议在这方面开展进一步的研究和临床试验设计。
{"title":"Successful Maintenance Treatment of a Patient with Resistant Hyperthyroidism with Traditional Persian Medicine Recommendations: A Case Report and Literature Review.","authors":"Mohammad Mahdi Parvizi, Sara Foolad, Ali Zeighami, Mohammad Reza Namazi, Mojtaba Heydari","doi":"10.1159/000541255","DOIUrl":"10.1159/000541255","url":null,"abstract":"<p><strong>Introduction: </strong>Hyperthyroidism is a common endocrinology condition that could affect several aspects of the patient's life.</p><p><strong>Case presentation: </strong>We present a 27-year-old woman who was sent to the traditional Persian medicine (TPM) clinic with a diagnosis of uncontrolled chronic hyperthyroidism (lower levels of thyroid-stimulating hormone (TSH) and higher levels of T3 and T4) and its complications, such as developing exophthalmos, palpitations, anxiety, sleep problems, hair loss, and dry skin. The patient was under treatment with prednisolone and methimazole for up to 1 year, but no acceptable improvement was achieved. The patient received a package of TPM recommendations, which included lifestyle modification, Melissa officinalis herbal tea, and Persian barley water. The patient was followed for 1 year. After 2 months of follow-up of the patient, the level of TSH increased, and the level of T3 and T4 decreased. In addition, the patient's symptoms, including exophthalmos, palpitation, anxiety, sleep disturbance, and dryness of the skin, were improved considerably. After 3 months of consumption of the TPM-based regime and prescription, the serum levels of TSH, T3, and T4, of the patient were in normal ranges. In a 1-year follow-up of the patient, the patient's condition was stable and her thyroid function tests were normal. We hereby present the following case to be in line with the CAse REports (CARE) checklist.</p><p><strong>Conclusion: </strong>It appears that TPM lifestyle recommendations, M. officinalis herbal tea, and Persian barley water were effective in treating the patient with uncontrolled hyperthyroidism. We recommend further studies and clinical trial designs in this regard.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"572-576"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Society Bulletins · Gesellschaftsmitteilungen. 学会公告 - 学会公告。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-11-15 DOI: 10.1159/000542372
{"title":"Society Bulletins · Gesellschaftsmitteilungen.","authors":"","doi":"10.1159/000542372","DOIUrl":"10.1159/000542372","url":null,"abstract":"","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":"31 6","pages":"593-598"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Migraine in an Adolescent with a Pineal Cyst Treated with Classical Individualized Homeopathy: A Case Report. 用经典个性化顺势疗法治疗患有松果体囊肿的青少年偏头痛 - 病例报告。
IF 1.8 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2023-12-14 DOI: 10.1159/000535615
Katarina Lucija Glas, Amritha Belagaje, Seema Mahesh, George Vithoulkas

Background: Migraine is one of the leading causes of morbidity and disability in the world. Its prevalence ranges from 5 to 40% in the pediatric population, with about 50% of these headaches continuing to adulthood. Incidental diagnosis of pineal cysts (PCs) is on the rise with the evolution of imaging techniques; the causal relationship of PC and individuals with headache however remains controversial, and complete resolution is uncommon. Conventional medicine stresses on the importance of tailored therapy in the management of pediatric migraine.

Case report: An 11-year-old female, diagnosed with migraine with an aura and PC, was benefitted by individualized classical homeopathic therapy using the homeopathic preparation Phosphorous and Natrum muriaticum. The symptoms of migraine improved, and the incidentally diagnosed PC completely resolved during the course of treatment.

Conclusion: Individualized classical homeopathy may have a role in effectively treating migraines and PCs in the pediatric population. There is a need for further scientific investigation with well-designed studies to prove the effectiveness of this therapeutic method, taking care to maintain the individualization principle of classical homeopathy.

HintergrundMigräne ist eine der führenden Ursachen für Krankheitslast und Behinderung weltweit. Ihre Prävalenz bei Kindern und Jugendlichen liegt im Bereich von 5–40%; hiervon sind etwa 50% bis ins Erwachsenenalter von den Kopfschmerzen betroffen. Zufallsdiagnosen von Pinealiszysten (PC) kommen im Zuge des Fortschritts bei den bildgebenden Verfahren immer häufiger vor, jedoch ist ein kausaler Zusammenhang der PC mit Kopfschmerzen umstritten, und ein vollständige Rückbildung kommt nicht häufig vor. Die Schulmedizin betont, wie wichtig eine maßgeschneiderte Therapie bei der Behandlung der Migräne im Kindesalter ist.FallberichtEin 11-jähriges Mädchen, bei dem eine Migräne mit Aura und eine Pinealiszyste diagnostiziert wurde, profitierte von einer individualisierten klassisch-homöopathischen Therapie mit den homöopathischen Präparaten Phosphorus und Natrum muriaticum. Die Migränesymptome besserten sich, und die zufällig diagnostizierte Pinealiszyste bildete sich im Laufe der Behandlung vollständig zurück.SchlussfolgerungDie individualisierte klassische Homöopathie kann bei der wirksamen Behandlung von Migräne und Pinealiszysten bei Kindern und Jugendlichen eine Rolle spielen. Es bedarf weiterer wissenschaftlicher Untersuchungen mit gutem Studiendesign, um die Wirksamkeit dieser Behandlungsmethode nachzuweisen, wobei darauf zu achten ist, das Individualisierungsprinzip der klassischen Homöopathie aufrechtzuerhalten.

背景:偏头痛是全球发病率和致残率的主要原因之一。偏头痛在儿童中的发病率为 5-40%,其中约 50%的头痛会持续到成年。随着成像技术的发展,松果体囊肿(PC)的偶然诊断率正在上升;然而,PC 与头痛患者的因果关系仍存在争议,而且完全缓解的情况并不常见。传统医学强调,在治疗小儿偏头痛时,有针对性的治疗非常重要:病例报告:一名被诊断为有先兆偏头痛和松果体囊肿的 11 岁女性,接受了使用顺势疗法制剂 "磷 "和 "鼠曲草 "的个性化经典顺势疗法。在治疗过程中,偏头痛症状得到改善,偶然诊断出的松果体囊肿也完全消退:经典顺势疗法可有效治疗儿童偏头痛和松果体囊肿。有必要进行进一步的科学调查,通过精心设计的研究来证明这种治疗方法的有效性,同时注意保持经典顺势疗法的个性化原则。
{"title":"Migraine in an Adolescent with a Pineal Cyst Treated with Classical Individualized Homeopathy: A Case Report.","authors":"Katarina Lucija Glas, Amritha Belagaje, Seema Mahesh, George Vithoulkas","doi":"10.1159/000535615","DOIUrl":"10.1159/000535615","url":null,"abstract":"<p><strong>Background: </strong>Migraine is one of the leading causes of morbidity and disability in the world. Its prevalence ranges from 5 to 40% in the pediatric population, with about 50% of these headaches continuing to adulthood. Incidental diagnosis of pineal cysts (PCs) is on the rise with the evolution of imaging techniques; the causal relationship of PC and individuals with headache however remains controversial, and complete resolution is uncommon. Conventional medicine stresses on the importance of tailored therapy in the management of pediatric migraine.</p><p><strong>Case report: </strong>An 11-year-old female, diagnosed with migraine with an aura and PC, was benefitted by individualized classical homeopathic therapy using the homeopathic preparation Phosphorous and Natrum muriaticum. The symptoms of migraine improved, and the incidentally diagnosed PC completely resolved during the course of treatment.</p><p><strong>Conclusion: </strong>Individualized classical homeopathy may have a role in effectively treating migraines and PCs in the pediatric population. There is a need for further scientific investigation with well-designed studies to prove the effectiveness of this therapeutic method, taking care to maintain the individualization principle of classical homeopathy.</p><p><p><title>Hintergrund</title>Migräne ist eine der führenden Ursachen für Krankheitslast und Behinderung weltweit. Ihre Prävalenz bei Kindern und Jugendlichen liegt im Bereich von 5–40%; hiervon sind etwa 50% bis ins Erwachsenenalter von den Kopfschmerzen betroffen. Zufallsdiagnosen von Pinealiszysten (PC) kommen im Zuge des Fortschritts bei den bildgebenden Verfahren immer häufiger vor, jedoch ist ein kausaler Zusammenhang der PC mit Kopfschmerzen umstritten, und ein vollständige Rückbildung kommt nicht häufig vor. Die Schulmedizin betont, wie wichtig eine maßgeschneiderte Therapie bei der Behandlung der Migräne im Kindesalter ist.<title>Fallbericht</title>Ein 11-jähriges Mädchen, bei dem eine Migräne mit Aura und eine Pinealiszyste diagnostiziert wurde, profitierte von einer individualisierten klassisch-homöopathischen Therapie mit den homöopathischen Präparaten Phosphorus und Natrum muriaticum. Die Migränesymptome besserten sich, und die zufällig diagnostizierte Pinealiszyste bildete sich im Laufe der Behandlung vollständig zurück.<title>Schlussfolgerung</title>Die individualisierte klassische Homöopathie kann bei der wirksamen Behandlung von Migräne und Pinealiszysten bei Kindern und Jugendlichen eine Rolle spielen. Es bedarf weiterer wissenschaftlicher Untersuchungen mit gutem Studiendesign, um die Wirksamkeit dieser Behandlungsmethode nachzuweisen, wobei darauf zu achten ist, das Individualisierungsprinzip der klassischen Homöopathie aufrechtzuerhalten.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"89-93"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138795980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Efficacy of the Herbal Formula of Bunium persicum and Coriandrum sativum on Clinical Symptoms of Patients with Functional Dyspepsia: A Double-Blind Randomized Controlled Trial. 杜仲和芫荽中药配方对功能性消化不良患者临床症状的疗效:一项双盲随机主动对照试验。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-07-17 DOI: 10.1159/000539472
Maryam Azimi, Mahboobeh Esfandiarpour, Mahboobeh Raeiszadeh, Faranak Salajegheh, Ali Saeidpour Parizi

Introduction: Functional dyspepsia (FD) is one of the most prevalent chronic disorders affecting up to 30% of the world population with considerable impairment of quality of life. This study evaluated the efficacy of the herbal preparation of Bunium persicum (Boiss.) B.Fedtsch. and Coriandrum sativum L. on symptom severity, symptom frequency, and quality of life of patients with FD.

Methods: This double-blind randomized controlled clinical trial, with parallel groups allocation ratio of 1:1, was conducted in a referral clinic of Afzalipour Hospital affiliated with Kerman University of Medical Sciences in Kerman, southeastern Iran. A total of 90 patients with FD (diagnosed based on the Rome IV criteria) were included in this study. The patients with complications during the intervention, pregnancy or lactation, a history of allergy to herbal drugs, use of other medication that affect the symptoms of FD during the study, and severe organic or psychiatric disorders were excluded. The participants received one capsule containing 500 mg of herbal preparation or placebo twice a day for 4 weeks and were subsequently followed up for 4 more weeks. Clinical outcomes were assessed via the Dyspepsia Severity Questionnaire, the Rome IV Diagnostic Questionnaire, and Nepean Dyspepsia Index Questionnaire.

Results: A total 40 participants in each group completed the follow-up period, and their data were analyzed statistically. All clinical outcomes showed significant improvements by herbal preparation compared to the placebo without serious side effects (p < 0.05).

Conclusions: This herbal preparation can significantly improve the quality of life, and symptoms of FD compared to placebo.

简介功能性消化不良(FD)是最普遍的慢性疾病之一,影响着全球多达 30% 的人口,严重损害了他们的生活质量。本研究评估了Bunium persicum (Boiss.) B.Fedtsch.和 Coriandrum Sativum L.草药配方对功能性消化不良患者症状严重程度、症状频率和生活质量的疗效:这项双盲随机对照临床试验在伊朗东南部克尔曼市的克尔曼医科大学附属阿夫扎利布尔医院转诊诊所进行,平行分组分配比例为 1:1。本研究共纳入了 90 名 FD 患者(根据罗马 IV 标准诊断)。排除了在干预期间出现并发症、怀孕或哺乳期、对草药有过敏史、在研究期间使用其他会影响 FD 症状的药物以及严重器质性或精神性疾病的患者。参与者每天两次服用含有 500 毫克草药配方或安慰剂的胶囊,每次一粒,连续服用 4 周,随后再随访 4 周。临床结果通过消化不良严重程度问卷、罗马IV诊断问卷和Nepean消化不良指数问卷进行评估:每组共有 40 名参与者完成了随访,并对他们的数据进行了统计分析。与安慰剂相比,中药配方的所有临床结果均有明显改善,且无严重副作用(P <0.05):结论:与安慰剂相比,该草药配方能明显改善 FD 的生活质量和症状。
{"title":"The Efficacy of the Herbal Formula of Bunium persicum and Coriandrum sativum on Clinical Symptoms of Patients with Functional Dyspepsia: A Double-Blind Randomized Controlled Trial.","authors":"Maryam Azimi, Mahboobeh Esfandiarpour, Mahboobeh Raeiszadeh, Faranak Salajegheh, Ali Saeidpour Parizi","doi":"10.1159/000539472","DOIUrl":"10.1159/000539472","url":null,"abstract":"<p><strong>Introduction: </strong>Functional dyspepsia (FD) is one of the most prevalent chronic disorders affecting up to 30% of the world population with considerable impairment of quality of life. This study evaluated the efficacy of the herbal preparation of Bunium persicum (Boiss.) B.Fedtsch. and Coriandrum sativum L. on symptom severity, symptom frequency, and quality of life of patients with FD.</p><p><strong>Methods: </strong>This double-blind randomized controlled clinical trial, with parallel groups allocation ratio of 1:1, was conducted in a referral clinic of Afzalipour Hospital affiliated with Kerman University of Medical Sciences in Kerman, southeastern Iran. A total of 90 patients with FD (diagnosed based on the Rome IV criteria) were included in this study. The patients with complications during the intervention, pregnancy or lactation, a history of allergy to herbal drugs, use of other medication that affect the symptoms of FD during the study, and severe organic or psychiatric disorders were excluded. The participants received one capsule containing 500 mg of herbal preparation or placebo twice a day for 4 weeks and were subsequently followed up for 4 more weeks. Clinical outcomes were assessed via the Dyspepsia Severity Questionnaire, the Rome IV Diagnostic Questionnaire, and Nepean Dyspepsia Index Questionnaire.</p><p><strong>Results: </strong>A total 40 participants in each group completed the follow-up period, and their data were analyzed statistically. All clinical outcomes showed significant improvements by herbal preparation compared to the placebo without serious side effects (p &lt; 0.05).</p><p><strong>Conclusions: </strong>This herbal preparation can significantly improve the quality of life, and symptoms of FD compared to placebo.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"416-426"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of the Utilization of Recognized Traditional and Complementary Medicine Service in Malaysia: A Secondary Analysis of a Cross-Sectional Population-Based Survey. 马来西亚使用公认的传统和补充医学服务的决定因素:对一项基于人口的横断面调查的二次分析。
IF 1.1 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-01-01 Epub Date: 2024-07-22 DOI: 10.1159/000540114
Suk Kuan Ng, Kimihiro Nishino, Zamtira Seman, Souphalak Inthaphatha, Eiko Yamamoto

Introduction: The utilization of traditional and complementary medicine (T&CM) services has witnessed a global increase over the past decades. Currently, seven practice areas are recognized in Malaysia: traditional Malay medicine (TMM), traditional Chinese medicine (TCM), traditional Indian medicine, homeopathy, Islamic medical practice, chiropractic, and osteopathy. Many global studies have investigated the general determinants of T&CM service utilization. However, there has been no comprehensive study reporting specific determinants of recognized T&CM service utilization. This study aimed to examine the prevalence and specific determinants of recognized T&CM service utilization in Malaysia at a national level.

Methods: This study is a secondary analysis of data from the National Health and Morbidity Survey (NHMS), a cross-sectional population-based survey conducted in Malaysia in 2015. A total of 6,207 respondents aged ≥18 years were included in this study. The associations of sociodemographic, health, and lifestyle factors with the utilization of the three T&CM service categories (TMM, TCM, and other T&CM) were examined using three separate logistic regression analyses.

Results: The prevalence of recognized T&CM service utilization in the last 12 months was 19.3%, with 15.0% for TMM, 3.9% for TCM, and 1.5% for other T&CM. The determinants of TMM service utilization were female sex; age range of 18-29 years; married or widowed/divorced status; Malay, indigenous, or other ethnicities; high household income; and being overweight/obese. The determinants of TCM service utilization were the age range of 30-49 years, urban residential location, Chinese ethnicity, and adequate fruit and vegetable intake. No specific determinants were identified for other T&CM.

Conclusion: This study provided novel evidence of a strong ethnocultural ownership toward traditional medicine. User profiles were distinctively different between varied T&CM services. Customized approaches to regulate, develop, and institutionalize specific T&CM services are crucial for fulfilling the unique needs of diverse communities.

导言:在过去的几十年里,全球对传统与补充医学(T&CM)服务的利用率不断提高。目前,马来西亚承认七种实践领域:传统马来医学、传统中医、传统印度医学、顺势疗法、伊斯兰医疗实践、脊椎按摩和整骨疗法。许多全球性研究都对使用传统中医服务的一般决定因素进行了调查。然而,还没有一项全面的研究报告了公认的中医药服务使用的具体决定因素。本研究旨在从国家层面研究马来西亚公认的 T&CM 服务利用率和具体决定因素:本研究对国家健康与发病率调查(NHMS)的数据进行了二次分析,NHMS是马来西亚于2015年开展的一项基于人口的横断面调查。本研究共纳入了6207名年龄≥18岁的受访者。通过三个独立的逻辑回归分析,研究了社会人口学、健康和生活方式因素与三类中医药服务(传统马来医药、传统中医药和其他中医药)使用情况的关系:过去 12 个月中使用过公认的中医药服务的比例为 19.3%,其中马来传统医药为 15.0%,传统中医药为 3.9%,其他中医药为 1.5%。使用马来传统医药服务的决定因素包括:女性;年龄在 18-29 岁之间;已婚或丧偶/离婚;马来、土著或其他族裔;家庭收入高;超重/肥胖。使用传统中医药服务的决定因素是 30-49 岁的年龄段、城市居住地、华裔以及充足的水果和蔬菜摄入量。结论:这项研究提供了新的证据,证明人们对传统医药有着强烈的民族文化认同感。各种传统医药服务的用户特征截然不同。为满足不同社区的独特需求,采用定制方法来规范、发展和制度化特定的传统医药服务至关重要。
{"title":"Determinants of the Utilization of Recognized Traditional and Complementary Medicine Service in Malaysia: A Secondary Analysis of a Cross-Sectional Population-Based Survey.","authors":"Suk Kuan Ng, Kimihiro Nishino, Zamtira Seman, Souphalak Inthaphatha, Eiko Yamamoto","doi":"10.1159/000540114","DOIUrl":"10.1159/000540114","url":null,"abstract":"<p><strong>Introduction: </strong>The utilization of traditional and complementary medicine (T&amp;CM) services has witnessed a global increase over the past decades. Currently, seven practice areas are recognized in Malaysia: traditional Malay medicine (TMM), traditional Chinese medicine (TCM), traditional Indian medicine, homeopathy, Islamic medical practice, chiropractic, and osteopathy. Many global studies have investigated the general determinants of T&amp;CM service utilization. However, there has been no comprehensive study reporting specific determinants of recognized T&amp;CM service utilization. This study aimed to examine the prevalence and specific determinants of recognized T&amp;CM service utilization in Malaysia at a national level.</p><p><strong>Methods: </strong>This study is a secondary analysis of data from the National Health and Morbidity Survey (NHMS), a cross-sectional population-based survey conducted in Malaysia in 2015. A total of 6,207 respondents aged ≥18 years were included in this study. The associations of sociodemographic, health, and lifestyle factors with the utilization of the three T&amp;CM service categories (TMM, TCM, and other T&amp;CM) were examined using three separate logistic regression analyses.</p><p><strong>Results: </strong>The prevalence of recognized T&amp;CM service utilization in the last 12 months was 19.3%, with 15.0% for TMM, 3.9% for TCM, and 1.5% for other T&amp;CM. The determinants of TMM service utilization were female sex; age range of 18-29 years; married or widowed/divorced status; Malay, indigenous, or other ethnicities; high household income; and being overweight/obese. The determinants of TCM service utilization were the age range of 30-49 years, urban residential location, Chinese ethnicity, and adequate fruit and vegetable intake. No specific determinants were identified for other T&amp;CM.</p><p><strong>Conclusion: </strong>This study provided novel evidence of a strong ethnocultural ownership toward traditional medicine. User profiles were distinctively different between varied T&amp;CM services. Customized approaches to regulate, develop, and institutionalize specific T&amp;CM services are crucial for fulfilling the unique needs of diverse communities.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"427-437"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Complementary Medicine Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1